AIMD
TECHNOLOGYAinos Inc
$1.77+0.04 (+2.31%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AIMD Today?
No stock-specific AI insight has been generated for AIMD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.26$4.50
$1.77
Fundamentals
Market Cap$13M
P/E Ratio—
EPS$-3.46
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume10K
Avg Volume (10D)—
Shares Outstanding7.3M
AIMD News
20 articles- VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical ScalabilityYahoo Finance·Apr 17, 2026
- Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital EnvironmentsYahoo Finance·Apr 8, 2026
- VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment MomentumYahoo Finance·Apr 1, 2026
- Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026Yahoo Finance·Mar 30, 2026
- RedChip AI Investor Conference Replays Now Available Featuring Public Companies Across the Artificial Intelligence Value ChainYahoo Finance·Mar 26, 2026
- The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor EnvironmentsYahoo Finance·Mar 19, 2026
- Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value ChainYahoo Finance·Mar 12, 2026
- Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026Yahoo Finance·Mar 9, 2026
- RedChip Showcases Public Companies Across the Artificial Intelligence Value Chain at March 19 Virtual Investor ConferenceYahoo Finance·Mar 9, 2026
- Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue OpportunityYahoo Finance·Mar 2, 2026
- Ainos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production EnvironmentsYahoo Finance·Feb 23, 2026
- Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS)Yahoo Finance·Feb 17, 2026
- Ainos initiates live AI Nose deployments within semi manufacturingYahoo Finance·Feb 10, 2026
- Ainos Initiates Live AI Nose Deployments within Semiconductor Manufacturing EnvironmentsYahoo Finance·Feb 9, 2026
- Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech ExpansionYahoo Finance·Feb 5, 2026
- Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value CreationYahoo Finance·Feb 4, 2026
- Ainos and Mirle Automation Partner to Bring Scent Intelligence to Robots and Quadruped RobotsYahoo Finance·Feb 2, 2026
- Ainos to Participate in Fireside Chat with Water Tower Research on January 26, 2026Yahoo Finance·Jan 20, 2026
- Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform ShiftYahoo Finance·Jan 12, 2026
- Ainos Announces Distribution Partnership with Trusval Technology to Expand AI Nose into Semiconductor Front-End ManufacturingYahoo Finance·Jan 7, 2026
All 20 articles loaded
Price Data
Open$1.74
Previous Close$1.73
Day High$1.78
Day Low$1.68
52 Week High$4.50
52 Week Low$1.26
52-Week Range
$1.26$4.50
$1.77
Fundamentals
Market Cap$13M
P/E Ratio—
EPS$-3.46
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume10K
Avg Volume (10D)—
Shares Outstanding7.3M
About Ainos Inc
Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
TECHNOLOGYSCIENTIFIC & TECHNICAL INSTRUMENTS
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICSCIENTIFIC & TECHNICAL INSTRUMENTS
CIK—
Composite FIGI—
Share Class FIGI—